Ftse Mib
34.475,55
0,04%
DAX
18.691,32
0,05%
S&P 500
5.305,52
-0,03%
NASDAQ
16.876,69
0,45%
Bitcoin
67.911,72
-1,72%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Labcorp Holdings Inc (LH) Labcorp Holdings Inc (LH) Notizie

LH

Labcorp (LH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:LH
DataOraFonteTitoloSimboloCompagnia
17/05/202422:57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LHLabcorp Holdings Inc
17/05/202422:45Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:LHLabcorp Holdings Inc
17/05/202422:41Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNYSE:LHLabcorp Holdings Inc
17/05/202422:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
17/05/202422:10Edgar (US Regulatory)Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)NYSE:LHLabcorp Holdings Inc
16/05/202422:19Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
16/05/202414:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
15/05/202414:00PR Newswire (US)Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during PregnancyNYSE:LHLabcorp Holdings Inc
14/05/202418:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLabcorp Holdings Inc
08/05/202412:59PR Newswire (US)Labcorp to Webcast Its Annual Meeting of ShareholdersNYSE:LHLabcorp Holdings Inc
07/05/202422:05PR Newswire (US)Invitae Receives Court Approval for Sale to LabcorpNYSE:LHLabcorp Holdings Inc
06/05/202422:40Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNYSE:LHLabcorp Holdings Inc
29/04/202413:00PR Newswire (US)Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BNYSE:LHLabcorp Holdings Inc
25/04/202412:58PR Newswire (US)Labcorp Announces 2024 First Quarter ResultsNYSE:LHLabcorp Holdings Inc
25/04/202403:27PR Newswire (US)Labcorp Announces Winning Bid for Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
25/04/202403:19PR Newswire (US)Invitae Enters into Agreement with Labcorp for Sale of BusinessNYSE:LHLabcorp Holdings Inc
15/04/202413:00PR Newswire (US)Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood DrawNYSE:LHLabcorp Holdings Inc
11/04/202412:59PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
10/04/202412:49PR Newswire (US)Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection KitNYSE:LHLabcorp Holdings Inc
08/04/202413:00PR Newswire (US)Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development ProgramsNYSE:LHLabcorp Holdings Inc
05/04/202413:00PR Newswire (US)Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical ResearchNYSE:LHLabcorp Holdings Inc
02/04/202413:00PR Newswire (US)Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer ResearchNYSE:LHLabcorp Holdings Inc
01/04/202414:00Business WireXcell Biosciences Strengthens Cell and Gene Therapy Collaboration With LabcorpNYSE:LHLabcorp Holdings Inc
29/03/202414:00PR Newswire (US)The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening LabNYSE:LHLabcorp Holdings Inc
28/03/202413:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNYSE:LHLabcorp Holdings Inc
27/03/202412:00PR Newswire (US)Labcorp to Announce First Quarter Financial Results on April 25, 2024NYSE:LHLabcorp Holdings Inc
20/03/202412:00PR Newswire (US)Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical TrialsNYSE:LHLabcorp Holdings Inc
16/03/202415:29PR Newswire (US)Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian CancerNYSE:LHLabcorp Holdings Inc
07/03/202413:00PR Newswire (US)Labcorp Launches Weight Loss Management Testing SolutionsNYSE:LHLabcorp Holdings Inc
21/02/202414:19GlobeNewswire Inc.Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardNYSE:LHLabcorp Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:LH

La tua Cronologia

BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
WBD
WeBuild
BIT
TITR
Telecom Italia
BIT
SRG
Snam
BIT
SPM
Saipem
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network